S. Aardal, K. Helle, S. Elsayed, and R. Reed, Vasostatins, Comprising the N-terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments, Journal of Neuroendocrinology, vol.123, issue.29, pp.405-412
DOI : 10.1073/pnas.88.4.1426

D. Aït-ali, V. Turquier, D. Alexandre, L. Grumolato, S. Jégou et al., FEBS Letters, vol.195, issue.1-3, pp.127-132, 2002.
DOI : 10.1016/S0344-0338(99)80090-9

Y. Anouar, T. Benie, D. Monti, M. Counis, R. Duval et al., Estradiol Negatively Regulates Secretogranin II and Chromogranin A Messenger Ribonucleic Acid Levels in the Female Rat Pituitary but Not in the Adrenal, Endocrinology, vol.129, issue.5, pp.2393-2399, 1991.
DOI : 10.1210/endo-129-5-2393

Y. Anouar, S. Jégou, D. Alexandre, I. Lihrmann, J. Conlon et al., Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides, FEBS Letters, vol.66, issue.3, pp.295-299, 1996.
DOI : 10.1046/j.1471-4159.1996.66062248.x

S. Barkatullah, W. Curry, C. Johnston, J. Hutton, and K. Buchanan, Ontogenetic expression of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendocrine system, Histochemistry and Cell Biology, vol.107, issue.3, pp.251-257, 1997.
DOI : 10.1007/s004180050110

U. Benedum, A. Lamouroux, D. Konecki, P. Rosa, A. Hille et al., The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region, EMBO J, vol.6, pp.1203-1211, 1987.

. Fig, 12A?F Reversed-phase HPLC analysis of WE14-and EL35-like immunoreactivity (li) in the human adrenal gland and in human pheochromocytoma . Tissue extracts from fetal adrenals (two glands from 20- week-old fetuses; A, B), adult adrenal (1 g tissue, p.1

E. , F. Were-prepurified-on-sep-pak-cartridges, W. , C. , E. et al., The bars above the peaks indicate the elution position of synthetic non-oxidized WE14 (peak I), oxidized WE14 (peak II), and EL35 (peak I) See legend to Fig

M. Blazquez, P. Bosma, J. Chang, K. Docherty, and V. Trudeau, Endocrinology, vol.139, issue.12, pp.4870-4880, 1998.
DOI : 10.1210/endo.139.12.6339

D. Cohn, J. Elting, M. Frick, and R. Elde, Selective Localization of the Parathyroid Secretory Protein-I/Adrenal Medulla Chromogranin A Protein Family in a Wide Variety of Endocrine Cells of the Rat*, Endocrinology, vol.114, issue.6, pp.1963-1974, 1984.
DOI : 10.1210/endo-114-6-1963

J. Conlon, B. Hamberger, and L. Grimelius, Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue, Peptides, vol.13, issue.4, pp.639-644, 1992.
DOI : 10.1016/0196-9781(92)90167-2

R. Cunningham, K. Pogue, W. Curry, C. Johnston, J. Sloan et al., Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids, The Journal of Pathology, vol.381, issue.3, pp.321-325, 1999.
DOI : 10.7326/0003-4819-120-4-199402150-00008

W. Curry, C. Johnston, J. Hutton, S. Arden, N. Rutherford et al., The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera, Histochemistry, vol.276, issue.6, pp.513-518, 1991.
DOI : 10.1007/BF00267079

W. Curry, C. Shaw, C. Johnston, L. Thim, and K. Buchanan, Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour, FEBS Letters, vol.288, issue.3, pp.319-321, 1992.
DOI : 10.1016/0014-5793(88)80606-9

L. Deftos, Chromogranin A: Its Role in Endocrine Function and as an Endocrine and Neuroendocrine Tumor Marker*, Endocrine Reviews, vol.12, issue.2, pp.181-187, 1991.
DOI : 10.1210/edrv-12-2-181

L. Deftos, A. Gazdar, R. Hogue-angeletti, P. Mullen, and D. Burton, Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells, Bone and Mineral, vol.9, issue.3, pp.169-178, 1990.
DOI : 10.1016/0169-6009(90)90035-E

B. Eriksson, H. Arnberg, K. Oberg, U. Hellman, G. Lundqvist et al., Chromogranins ??? New Sensitive Markers for Neuroendocrine Tumors, Acta Oncologica, vol.324, issue.3, pp.325-329, 1989.
DOI : 10.1038/324476a0

N. Eskeland, A. Zhou, T. Dinh, H. Wu, R. Parmer et al., Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway., Journal of Clinical Investigation, vol.98, issue.1, pp.148-156, 1996.
DOI : 10.1172/JCI118760

R. Fischer-colbrie, T. Wohlfarter, K. Schmid, M. Grino, and H. Winkler, Dexamethasone induces an increased biosynthesis of chromogranin A in rat pituitary gland, Journal of Endocrinology, vol.121, issue.3, pp.487-494, 1989.
DOI : 10.1677/joe.0.1210487

H. Gerdes, P. Rosa, E. Phillips, P. Baeuerle, R. Franck et al., The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH-and calcium-induced aggregation, J Biol Chem, vol.264, pp.12009-12015, 1989.

C. Gleeson, W. Curry, C. Johnston, and K. Buchanan, Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia, Journal of Endocrinology, vol.151, issue.3, pp.409-420, 1996.
DOI : 10.1677/joe.0.1510409

A. Heaney, W. Curry, K. Pogue, V. Armstrong, M. Mirakhur et al., Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas, Pituitary, vol.3, issue.2, pp.67-75, 2000.
DOI : 10.1023/A:1009949623054

K. Helle, The Chromogranins, Adv Exp Med Biol, vol.482, pp.3-20, 2000.
DOI : 10.1007/0-306-46837-9_1

J. Holthuis and G. Martens, The Neuroendocrine Proteins Secretogranin II and III Are Regionally Conserved and Coordinately Expressed with Proopiomelanocortin in Xenopus Intermediate Pituitary, Journal of Neurochemistry, vol.66, issue.6, pp.2248-2256, 1996.
DOI : 10.1046/j.1471-4159.1996.66062248.x

A. Iacangelo and L. Eiden, Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway, Regulatory Peptides, vol.58, issue.3, pp.65-88, 1995.
DOI : 10.1016/0167-0115(95)00069-N

A. Iacangelo, H. Affolter, L. Eiden, E. Herbert, and M. Grimes, Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues, Nature, vol.5, issue.6083, pp.82-86, 1986.
DOI : 10.1128/MCB.3.2.280

A. Iacangelo, R. Fischer-colbrie, K. Koller, M. Brownstein, and L. Eiden, THE SEQUENCE OF PORCINE CHROMOGRANIN A MESSENGER RNA DEMONSTRATES CHROMOGRANIN A CAN SERVE AS THE PRECURSOR FOR THE BIOLOGICALLY ACTIVE HORMONE, PANCREASTATIN, Endocrinology, vol.122, issue.5, pp.2339-2341, 1988.
DOI : 10.1210/endo-122-5-2339

R. Ischia, R. Gasser, R. Fischer-colbrie, U. Eder, A. Pagani et al., Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-360, 2000.
DOI : 10.1210/jc.85.1.355

S. Jégou, M. Tonon, P. Leroux, C. Delarue, F. Leboulenger et al., Immunological characterization of endorphins, adrenocorticotropin, and melanotropins in frog hypothalamus, General and Comparative Endocrinology, vol.51, issue.2, pp.246-254, 1983.
DOI : 10.1016/0016-6480(83)90078-3

T. Kim, J. Tao-cheng, L. Eiden, and Y. Peng-loh, Chromogranin A, an ???On/Off??? Switch Controlling Dense-Core Secretory Granule Biogenesis, Cell, vol.106, issue.4, pp.499-509, 2001.
DOI : 10.1016/S0092-8674(01)00459-7
URL : https://doi.org/10.1016/s0092-8674(01)00459-7

B. Leitner, C. Schneitler, H. Klocker, W. Volknandt, H. Zimmermann et al., Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin II, in mammalian, bird, reptile, amphibian and fish brains, Neuroscience Letters, vol.248, issue.2, pp.105-108, 1998.
DOI : 10.1016/S0304-3940(98)00345-0

J. Leprince, P. Gandolfo, J. Thoumas, C. Patte, J. Fauchere et al., Journal of Medicinal Chemistry, vol.41, issue.23, pp.4433-4438, 1998.
DOI : 10.1021/jm980275d

K. Lugardon, R. Raffner, Y. Goumon, A. Corti, A. Delmas et al., Antibacterial and Antifungal Activities of Vasostatin-1, the N-terminal Fragment of Chromogranin A, Journal of Biological Chemistry, vol.262, issue.15, pp.10745-10753, 2000.
DOI : 10.1210/en.137.7.2918
URL : https://hal.archives-ouvertes.fr/hal-02146721

S. Mahata, M. Mahata, A. Wakade, O. Connor, and D. , Primary structure and function of the catecholamine release inhibitory peptide catestatin [chromogranin A(344?364)]: identification of amino acid residues crucial for activity, Mol Endocrinol, vol.14, pp.1525-1535, 2000.

M. Marcinkiewicz, R. Day, N. Seidah, and M. Chrétien, Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin., Proceedings of the National Academy of Sciences, vol.90, issue.11, pp.4922-4926, 1993.
DOI : 10.1073/pnas.90.11.4922

R. Matteri, J. Roser, D. Baldwin, V. Lipovetsky, and H. Papkoff, Characterization of a monoclonal antibody which detects luteinizing hormone from diverse mammalian species, Domestic Animal Endocrinology, vol.4, issue.3, pp.157-165, 1987.
DOI : 10.1016/0739-7240(87)90011-7

M. Metz-boutigue, P. Garcia-sablone, R. Hogue-angeletti, and D. Aunis, Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites, European Journal of Biochemistry, vol.13, issue.1, pp.247-257, 1993.
DOI : 10.1016/0014-5793(86)80002-3

P. Norlén, W. Curry, D. Chen, C. Zhao, C. Johnston et al., Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells, Regulatory Peptides, vol.70, issue.2-3, pp.121-133, 1997.
DOI : 10.1016/S0167-0115(97)00021-9

P. Norlén, W. Curry, M. Bjorkqvist, A. Maule, R. Cunningham et al., Cell-specific Processing of Chromogranin A in Endocrine Cells of the Rat Stomach, Journal of Histochemistry & Cytochemistry, vol.260, issue.1, pp.9-18, 2001.
DOI : 10.1016/0306-4522(86)90154-5

D. Connor and K. Bernstein, Radioimmunoassay of Chromogranin a in Plasma as a Measure of Exocytotic Sympathoadrenal Activity in Normal Subjects and Patients with Pheochromocytoma, New England Journal of Medicine, vol.311, issue.12, pp.764-770, 1984.
DOI : 10.1056/NEJM198409203111204

D. Connor, R. Frigon, and R. Sokoloff, Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma, Hypertension, vol.6, issue.1, pp.2-12, 1984.
DOI : 10.1161/01.HYP.6.1.2

G. Portel-gomes, L. Grimelius, H. Johansson, and E. Wilander, Chromogranin A in Human Neuroendocrine Tumors, The American Journal of Surgical Pathology, vol.25, issue.10, pp.1261-1267, 2001.
DOI : 10.1097/00000478-200110000-00006

P. Rosa and H. Gerdes, The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors, Journal of Endocrinological Investigation, vol.85, issue.3, pp.207-225, 1994.
DOI : 10.1172/JCI114604

M. Stridsberg, R. Angeletti, and K. Helle, Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods, Journal of Endocrinology, vol.165, issue.3, pp.703-714, 2000.
DOI : 10.1677/joe.0.1650703

K. Tatemoto, S. Efendic, V. Mutt, G. Makk, G. Feistner et al., Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion, Nature, vol.5, issue.6096, pp.476-478, 1986.
DOI : 10.1038/324476a0

D. Tranchant-bunel, J. Conlon, N. Chartrel, M. Tonon, and H. Vaudry, Isolation and structural characterization of peptides related to ??- and ??-melanocyte-stimulating hormone (MSH) from the frog brain, Molecular Brain Research, vol.15, issue.1-2, pp.1-7, 1992.
DOI : 10.1016/0169-328X(92)90143-Y

V. Turquier, H. Vaudry, S. Jégou, and Y. Anouar, Endocrinology, vol.140, issue.9, pp.4104-4112, 1999.
DOI : 10.1210/endo.140.9.6976

V. Turquier, H. Vaudry, M. Montero, Y. L. Anouar, and Y. , Characterization of Chromogranins in the Frog Rana ridibunda, 2000.
DOI : 10.1007/0-306-46837-9_9

, expression, and functional implications, Structure Adv Exp Med Biol, vol.482, pp.125-136

H. Vaudry and J. Conlon, Identification of a peptide arising from the specific post-translation processing of secretogranin II, FEBS Letters, vol.30, issue.1, pp.31-33, 1991.
DOI : 10.1016/0306-4522(89)90368-0

T. Watanabe, T. Banno, T. Jeziorowski, Y. Ohsawa, S. Waguri et al., Endocrinology, vol.139, issue.6, pp.2765-2773, 1998.
DOI : 10.1210/endo.139.6.6059

C. Wiedermann, Secretoneurin: a functional neuropeptide in health and disease, Peptides, vol.21, issue.8, pp.1289-1298, 2000.
DOI : 10.1016/S0196-9781(00)00271-0

H. Winkler and R. Fischer-colbrie, The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992.
DOI : 10.1016/0306-4522(92)90222-N

T. Wohlfarter, R. Fischer-colbrie, R. Hogue-angeletti, L. Eiden, and H. Winkler, Processing of chromogranin A within chromaffin granules starts at C- and N-terminal cleavage sites, FEBS Letters, vol.211, issue.1, pp.67-70, 1988.
DOI : 10.1016/0014-5793(87)81425-4

M. Wolkersdorfer, A. Laslop, C. Lazure, R. Fischer-colbrie, and H. Winkler, -tyrosine, Biochemical Journal, vol.316, issue.3, pp.953-958, 1996.
DOI : 10.1042/bj3160953